Navigation Links
A Host of New Products to be Showcased at 2010 Molecular Medicine Tri-Conference

Cambridge Healthtech Institute announces twenty-four exhibitors to showcase new products at the 17th Molecular Medicine Tri-Conference, taking place February 3-5, at the Moscone Convention Center, San Francisco, CA. The Molecular Medicine Tri-Conference is the predominant event on the west coast focused on integrating the entire spectrum of drug development.

Needham, MA (PRWEB) January 12, 2010 -- The Molecular Medicine Tri-Conference has experienced six straight years of attendee growth, while maintaining a high quality audience. This year's event is on track to be another successful event. Spanning three days, the meeting is built around 6 scientific channels, encompassing 11 conferences, providing attendees more learning opportunities than ever before.

The 2010 event will include for the first time the New Product Pavilion, where 30 companies will showcase their new products to event attendees.

New Products Include:

Asterand; human tissue services                                                            
Axxin; Molecular Diagnostics Tools & Services
Chemical Computing Group; molecular operating environment        
Epicentre Biotechnologies; Nextera™, DNA Sample Prep Kits                        
Esoterix Clinical Trials Services; companion diagnostics/biorepository    
ExonHit Therapeutics; AclarusDx™ Alzheimer's test
GeneGo; Eureka!™
GenVault Corporation; GenTegra™ RNA/GenTegra™ DNA    
GENOMETRICA; Instrumentation for Molecular Diagnostics
IDBS; The Biomarker Discovery and Validation Solution
Infosys Technologies; Scientific Innovation Solution    
Ingenuity Systems; Ingenuity® Answers        
Linguamatics; I2E 3.1            
Mercodia; Rat/Mouse Proinsulin ELISA
MitoProd; ciRNA® Circular Interfering RNA    
NanoInk; nanoscale protein arrays        
NanoString Technologies; nCounter Gene Expression Panels
Novartis Molecular Diagnostics; Diagnostic Assays & Molecular Diagnostics Reagents
Optibrium; StarDrop™                    
Parthys Reverse Informatics Analytic Solutions; thematic database/services
Prestwick Chemical Inc.; New Prestwick Chemical Library    
Primax Biosciences; iPorator-96
SCHOTT North America, Inc.; Nexterion® Slide NC
Sigma Aldrich; Stemgent® Reprogramming Lentivirus for iPSC
Thomson Reuters; Prous Science Integrity and Biomarker Center
Transgenomic Inc.; cold PCR                
Trans-Hit Biomarkers, International directory of biobanks/Worldwide in-licensing biomarkers opportunities    
TriLink BioTechnologies; CleanAmp™ dNTPs
WiCell Research Institute; Cytogenetic Testing Services    
Zeptosens; ZeptoVIEW 3 - Reverse Array Protein Profiling Software for ZeptoMARK Booth # 213

About Molecular Medicine Tri-Conference
Molecular Medicine Tri-Conference -- the flagship event of CHI - has built this year's event around 6 scientific channels, encompassing 11 conferences, providing attendees more learning opportunities than ever before. Featured channels include diagnostics, chemistry, informatics, biologics, cancer and executive. We are looking to provide attendees a more in depth experience into each of these six areas of research and development. As the need for better information, new technologies, improved strategies and competitive intelligence becomes ever more acute, this event provides compelling research insight into the future of molecular medicine. In 2010, we expect close to 3,000 attendees, 1200 participating companies, 150 exhibitors, 100 posters, and representatives from over 38 countries.

About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Tracey Fielding
Cambridge Healthtech Institute


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. IsoTis Receives FDA Clearance for Accell Family of Products
2. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
3. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
4. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
5. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
6. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
7. Debiopharm Receives cGMP Certification for Quality Control of its Drug Products
8. Bioscrypts V-Station MIFARE Placed on Transportation Security Administrations Qualified Products List
9. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
10. AMDLs Jade Pharmaceutical Subsidiary Announces New Product Strategy; Six New Products, Including One With Sales Projected at Upwards of $10 Million, Under Development
11. NanoBio Expands Drug Development Team for Its Anti-Infective Products
Post Your Comments:
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Paris from 17 th ... Paris from 17 th until 19 th ... has invented the first combined scanner in the world which ... surface. Until now two different scanners were required: one for ... on the same surface. This innovation is an ideal ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
Breaking Biology News(10 mins):